Catherine Berry
Marcy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.
Journal: NPJ vaccines
Published: August 11, 2025
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.
Journal: Nature communications
Published: December 12, 2022
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.
Journal: Communications medicine
Published: August 19, 2022
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.
Journal: Nature communications
Published: September 03, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.
Journal: bioRxiv : the preprint server for biology
Published: March 10, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.
Journal: Science translational medicine
Published: March 10, 2021
Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
Journal: Vaccine
Published: January 15, 2019
Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes.
Journal: Vaccine
Published: September 27, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026